NewEdge Advisors’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $361K | Buy |
1,257
+403
| +47% | +$116K | ﹤0.01% | 1902 |
|
|
2025
Q1 | $263K | Sell |
854
-2,173
| -72% | -$670K | ﹤0.01% | 1969 |
|
|
2024
Q4 | $1.07M | Buy |
3,027
+1,679
| +125% | +$592K | 0.01% | 1122 |
|
|
2024
Q3 | $483K | Buy |
1,348
+480
| +55% | +$172K | ﹤0.01% | 1503 |
|
|
2024
Q2 | $277K | Buy |
868
+847
| +4,033% | +$270K | ﹤0.01% | 1763 |
|
|
2024
Q1 | $4.82K | Buy |
21
+6
| +40% | +$1.38K | ﹤0.01% | 3150 |
|
|
2023
Q4 | $3.3K | Hold |
15
| – | – | ﹤0.01% | 3233 |
|
|
2023
Q3 | $3.39K | Sell |
15
-7
| -32% | -$1.58K | ﹤0.01% | 2915 |
|
|
2023
Q2 | $4.86K | Sell |
22
-942
| -98% | -$208K | ﹤0.01% | 2831 |
|
|
2023
Q1 | $216K | Sell |
964
-1,261
| -57% | -$282K | ﹤0.01% | 1512 |
|
|
2022
Q4 | $615K | Sell |
2,225
-171
| -7% | -$47.2K | 0.02% | 697 |
|
|
2022
Q3 | $502K | Buy |
+2,396
| New | +$502K | 0.01% | 962 |
|
|
2022
Q1 | – | Sell |
-1,257
| Closed | -$272K | – | 1625 |
|
|
2021
Q4 | $272K | Buy |
+1,257
| New | +$272K | ﹤0.01% | 1370 |
|